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Abstract
Improving quality in US physiotherapeutical treatments is mandatory in order to get 
‘evidence‐based’ clinical results. This implies quality assurance protocols for the equip‐
ment, as well as some tentative dosimetrical approaches to predict local heating in 
joints following US parameter setting and operative modality. Finally, the possibility of 
‘personalized therapy’ with multimodal (by qualitative and quantitative, e.g. based on 
sonography) assessment is discussed.
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1. Introduction
Therapeutic ultrasound (US) is performed in physiotherapy to treat a variety of inflammatory 
and post‐traumatic diseases. Most of their effects depend on the induction of local thermal 
increases, which elicit local vasodilatation and toxic substances washout; however, specific 
and quantitative effects are often misconsidered in physiotherapy units. Moreover, despite 
its widespread use in rehabilitative practice and a large number of studies, low scientific, 
statistically assessed evidences of therapeutic US effectiveness are available. As a matter of 
fact, details about the treatment modalities and the way in which the patients’ feedback was 
collected are often missing. The chapter will be focused on the following points:
(1) Physical bases, technical approach and quality assurance of ultrasonic equipment: tech‐
nological development and wide use of US within the patient's rehabilitation program 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
led to the need for a thorough understanding of the interaction between ultrasonic waves 
and biological matter. Scientific evidence of US therapeutic effectiveness in rehabilitation 
fields requires more attention on the technical specifications of devices used, and the exact 
parameters applied in the treatment of selected patients in order to avoid standardized 
US treatments using ‘protocols’ and non‐specific parameter settings.
(2) Towards physiotherapeutic US dosimetry: treatment planning by the assessment of 
thermal and mechanical effects. Quantitative assessment of thermal and mechanical 
effects, and their dependence on the US parameters (frequency, emitted power, pulsed or 
continue waves) and the treatment modalities (fixed field or massage, duration of the 
treatment) may be quantitatively investigated on joint mimicking phantoms made of 
muscle‐equivalent agar‐based material and bone disks. ‘In vitro’ temperature increases 
can be predicted, which are the ‘asymptotical values’ in the absence of blood perfusion 
and other heat dissipation mechanisms.
(3) Customized ‘in‐patient’ assessment of clinical effects: clinical, functional and sonogra‐
phycal evaluation can/should be performed before and at the end of the US therapy us‐
ing Numeric Rating Scale, Constant Score, DASH questionnaire and sonographic images 
supporting clinical and functional data.
2. Main body
2.1. Physical bases, technical approach and quality assurance of ultrasonic equipment
Ultrasound (US) is a mechanical non‐ionizing radiation, which propagates in a medium 
transferring energy from one particle to another by molecular oscillation. The longitudi‐
nal waves (compression) can propagate in any medium, while the transverse waves are 
observed only in solids, because of the weak links that are established between atoms and 
molecules in the tissue fluids. The ultrasonic wave is mainly longitudinal in biological tis‐
sues and characterized by alternating compression and rarefaction of the medium in which 
it propagates, with variations in pressure within it. Related to the pressure amplitude, which 
describes the degree of compression and rarefaction and thus the strength per unit area to 
which the material is subjected in unit of Pascal (Pa = N/m2) and its multiples (e.g. MPa), 
also the concept of power of an ultrasound beam, i.e. the energy transmitted in the time unit 
measured in Watt and that of wave intensity, that is the amount of energy flowing in the time 
unit through a surface of unit area, perpendicular to the direction of wave propagation (mea‐
sured in W/cm2) are important. The intensity varies over time both in the case of continuous 
wave (CW) or pulsed wave (PW): in particular, the presence of a pulsed field introduces 
a temporal variation, defining a duty cycle (DC) as the ratio between the pulse duration 
ultrasound (in time units) and the length of the period, calculated as a percentage. Therapies 
that employ the US can be divided into two groups: ‘high power’ and ‘low power’ [1]. The 
high power applications include HIFU (high‐intensity focused ultrasounds) and lithotripsy, 
while low‐power applications include physical therapy, sonophoresis, sonoporation and 
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gene therapy. When a US wave proceeds from one medium to another, it is partly reflected 
and partly transmitted, according to the laws of classical mechanics. Each medium is inher‐
ently characterized by a complex quantity, the impedance Z, which synthesizes the acoustic 
characteristics of the medium and quantifies the resistance that the medium itself opposes 
the passage of sound waves. The acoustic impedance is defined as the product of the density 
ρ of the medium (kg/m3) for the propagation velocity c (m/s)
  Z = ρc (1)
Its unit of measure is Pa s/m or Rayl, named after the famous British scientist Lord Rayleigh, 
which is equivalent to kg/m2 s. Propagating in a medium, the acoustic wave is subject to a pro‐
gressive loss of energy and, more properly, it causes a decrease in the intensity as a function of 
distance from the source. This is due both to the absorption, where the mechanical energy of 
the waves is partially converted into heat, and to the scattering, where the interaction between 
the wave and any inhomogeneous structure in the medium determines a partial diffusion of 
energy along directions different from that of direct wave propagation.
The overall effect, in a homogeneous medium, is such that a field of wave initial intensity I
0
 
after a certain distance z, has an intensity, which decreases exponentially according to the 
equation:
  I =    I 
0
  exp (− 2αz ) (2)
where I
0
 is the initial intensity I α and the absorption coefficient of the medium (cm‐1).
The energy absorption of ultrasound within the medium (and the biological tissues as well) 
depends on the frequency of the waves, being the coefficient of attenuation α inversely depen‐
dent on the square of the frequency. This is responsible for the fact that most of the tissues 
crossed by US exhibit an increase in the absorption coefficient of at least three times when the 
frequency is increased from 1 to 3 MHz (e.g. from 0.14 to 0.42 cm‐1 in fat, from 1.12 to 3.36 cm‐1 
in tendons, from 0.76 to 2.28 cm‐1 in muscle).
Lower absorption (and therefore higher penetration) of the ultrasonic wave is observable in 
water and in fact as tissue rich in water, and therefore the local heating is not significant. 
On the contrary, the absorption is much higher in the bone tissue and tendons [2]. In gen‐
eral, soft tissues absorb about 10–20% of the emitted power per centimetre, while adult bone 
completely absorbs the ultrasound beam in short distances. US at the frequency of 1 MHz is 
mainly absorbed by tissues that are 3–5 cm from the probe, and precisely for this property 
they are recommended for deeper lesions and in patients with subcutaneous fat [3].
Note that 3 MHz frequency is instead recommended for more superficial lesions, e.g. 1–2 cm 
deep [3, 4]. All the above parameters contribute to the effects of US in biological tissues, which 
are normally accounted for as ‘thermal’ and ‘non‐thermal’ effects.
(i) Thermal effects: When US loose energy and the beam is attenuated due to the absorption 
and dissipation of the ultrasonic energy, heat is produced by vibration, shock, and friction 
with the cellular and intercellular structures of the crossed tissues. The temperature increase 
that occurs in the medium can cause chemical or structural changes in biopolymers.
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This phenomenon is influenced by both the characteristics of the ultrasound beam (intensity 
and frequency), the duration of exposure and the characteristics of the crossed tissues (acous‐
tic impedances). Heating is established quickly; however, a thermal equilibrium due to the 
heat dissipation due to blood flow is reached in longer times.
The thermal effect is most evident at the interface between tissues and in particular at the 
interface between fat and muscle and at the level of the periosteum. The periosteum, for its 
anatomical structure and for the continuity with the bone, absorbs a large amount of energy 
and is therefore easily heated. The thermal elevation generates, as secondary effects, increase 
in cellular metabolism and vasodilation; in particular, the latter property is important in the 
use of therapeutic US in physiotherapy, promoting the wash‐out of pro‐inflammatory sub‐
stances and pro‐algogenic tissues.
(ii) Non‐thermal effects: They include cavitation, which consists in the formation, growth and 
implosion of gas bubbles within the fluid subjected to an ultrasonic field. In general, the cavi‐
tation can be seen as the ‘break’ of a liquid and the consequent formation inside the same of 
‘cavities’ (bubbles) of the liquid containing dissolved gas or vapour itself. This phenomenon 
occurs in many situations, for example, in boiling water or in proximity to the propeller in 
rotation of a ship, and in any case when liquids are subject to high and rapid changes in pres‐
sure and can occur in the use of therapeutic US or in Doppler ultrasound [5].
The almost instantaneous variations of density, pressure and temperature of the fluid in 
which propagates the ultrasonic wave can also produce the so‐called shock waves or pressure 
waves which can also be extremely intense. The ultrasonic irradiation of water leads to the 
formation of the hydroxyl radical and hydrogen radical, which give as the main final products 
H
2
O
2
 (hydrogen peroxide) and H
2
.
At the cellular level, the production of radicals induced by exposure to the US can also produce 
biological effects on DNA; theoretical models and experimental studies have shown that the 
effects of the US on biopolymers especially relate to the degradation pattern of structures [6].
The specificity of the effects stresses the need for accurate quality assessment, by specific 
acoustic measurements on the clinical equipment.
The performances of the equipment have been investigated, especially on a local basis, by 
many authors (see Refs. [7–10]), and recommendations have been proposed [11]. For exam‐
ple, the Italian National Institute of Metrological Research (INRIM) settled a protocol [12] for 
evaluating the ultrasonic power produced by clinical equipment using the Radiation Force 
Balance (RFB) method. The ultrasonic power is actually determined by the measurement of 
the force exerted on a target by the sound field generated from an ultrasonic source. The 
absorbing, connected to the load cell, measures the apparent mass variation due to the ultra‐
sonic field when the source is alternately switched on and off.
2.2. Towards therapeutic US dosimetry: treatment planning by ‘in vitro’ parameter 
evaluation
Most of the therapeutic applications of US induce heating in insonated tissues to obtain some 
beneficial effect. By increasing temperature a few degrees above the normothermic levels, it 
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is possible to induce temporary vasodilation and increase blood inflow in the affected area, 
performing a sort of ‘thermotherapy’. This mechanism has been proposed as the principal 
one to explain the therapeutic effects obtained in physiotherapy applications: the analgesic 
effect in the joints and muscles is mediated by vasodilation and by the subsequent wash‐out 
of pro‐algogenic substances and pro‐inflammatory with local edema reduction. In addition, 
the increase of tissue temperature promotes a higher extensibility of soft tissue, and a relax‐
ing effect on the muscles; the increase of cell activity and of the local metabolism caused by 
the heat stimulates the accelerated wound healing and repair of tendon injuries, ligament, 
muscle, etc.
Even non‐thermal effects (cavitation, emulsion, streaming and sonoporation) may play a role 
in the physiotherapy field: they, in fact, generate a sort of ‘micro‐massage’ in tissues, promote 
the increase of local blood flow; furthermore, at cellular and intracellular level, US induces an 
increase of membrane permeability, calcium uptake, protein synthesis, mast cell degranula‐
tion, production of growth factors, angiogenesis, increased fibroblast motility and orientation 
modification of the fibres collagen and shift the type of collagen (type III to type I) in tissue 
repair [13].
Controindications to the therapeutic US are possibly due to interference with other electronic 
devices (e.g. cardiac pacemaker) or are related to the possible effects induced from heat and 
cavitative phenomena.
US can cause damage to eyes, gonads, encephalon and ears, and the presence of growing 
cartilage remains the most substantial downside.
It is also recommended not to use the US in body regions where there are implants or metal‐
lic synthesis; in fact, given the large difference in impedance between these materials and 
human tissues, areas of friction and heat accumulation can be formed, with unpredictable 
consequences.
It is also not recommended for any kind of treatment with US in the presence of malignancies, 
to avoid the spread in a circle of pathogenic cell lines. In order to get the therapeutic effects 
described above, it is mandatory to know how US may increase local temperature depending 
on the setting of the main parameters (frequency, power, etc.) and the modality of treatment 
(CW, PW, etc.). Although in living tissues many biological mechanisms may dissipate heat, 
preliminary investigations on ‘in vitro’ phantoms may help in finding the ‘asymptotic’ values 
of the thermal increase locally induced by the US. Many approaches have been proposed 
in the literature [see 14–16], based on different test materials exhibiting the same mechani‐
cal and thermal properties of homogeneous tissues. Also, numerical simulations have been 
proposed [17].
The use of ‘tissue‐mimicking phantoms', coupling different tissues (e.g. muscle‐equivalent 
and bone), as the two presented in Figure 1 to simulate a superficial (A) and a deep (B) joint, 
respectively, may be useful to evaluate the temperature at different depth depending on the 
choice of the parameter values of the equipment and the different treatment protocols [18].
A cartoon cylinder filled with homemade agar‐based gel, prepared using bi‐distilled water 
(86.5%), glycerine (5.5%), graphite (2%), agar (2.5%) and salicylic acid (traces) was produced. 
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The phantom contains at one end a bovine bone disk 2 (±1) mm thick inserted at 3 (±0.5) cm 
depth (simulating a ‘deep joint’) and at the other end a bovine bone disk 1 (±0.5) mm thick 
inserted at 1 (±0.5) cm (simulating a ‘superficial joint’) (see Figure 1A and B). The two disks 
were always fixed approximately in the centre of the phantom, and their diameter was 
always smaller than one‐half of the phantom diameter. Deep and superficial ‘joints’ were 
treated at 1 and 3 MHz, respectively, using the equipment Enraf Nonius SonoPlus. Thermal 
probes, inserted at different depth, perform temperature measurements before, during and 
after sonications lasting 5 min and performed using the most diffused clinical treatment 
modalities (e.g. selecting ‘continuous’ (CW) or ‘pulsed’ (PW) wave on the apparatus and 
keeping fixed or massaging the probe on the phantom surface). Such massaging is per‐
formed by small circular movements where the probe is freely and randomly moved on the 
phantom cross section. The temperature increases detected into the phantoms are different 
in superficial and deep joints, and mainly depends on the operating mode (CW or PW) and 
on the fixed or massage modality selected for the probe application. The (min‐max) tempera‐
ture increases detected at different positions (see Figure 1) and with different modalities are 
given in Table 1.
Figure 1. Scheme of the phantoms mimicking a superficial (A) and a deep (B) joint indicating the position of the bone 
insert and of the temperature probes.
3 MHz
T1 T2 T3
CW: (5–10) CW: (10–12.5) CW: (5–15)
PW: (0–2.5) PW: (0–2.5) PW: (2.5–5)
1 MHz
T1 T2 T3
CW: (5–7.5) CW: (5–7.5) CW: (2.5–5)
PW: (0–2.5) PW: (0–2.5) PW: (0–2.5)
Table 1. (Min‐max) temperature increase (in °C).
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PW modality is always safer, while CW can induce temperature peaks (hot‐spots) at different 
depth inside the joint.
The local characteristics of the thermal field are not easily predictable based only on wave 
attenuation, because the bone insertions influence the temperature distribution. In Ref. [18] 
also the mechanical effects may be detected by inserting contrast agents (e.g. nanobubbles 
[19]), which can be exploded when the US pressures exceed some threshold values, but no 
significant differences could be detected in the nanobubbles diameter distribution before and 
after US sonication. As a consequence, very accurate and anatomically based experimental and 
numerical models are required to predict the thermal field inside any particular joint or non‐
homogeneous body region. The starting points should be joints which most benefit from phys‐
iotherapeutic US [20, 21], and in particular, shoulders, which often suffer from muscle‐skeleton 
diseases treated with US [22]. On any specific pathologies, such specifically those affecting the 
shoulders, the previous investigations on phantoms may be useful to perform some ‘treatment 
planning’ based on the different anatomical and functional features [23], as shown in Table 2.
3. ‘Customized’ ‘in‐patient’ assessment of clinical effects
Very often physiotherapeutic US is applied by using ‘protocols’ which sets the same treat‐
ment parameters values (e.g. duration and treatment modalities) for all patients and all kind 
of diseases [22, 24]. In everyday clinical practice, it is uncommon to give a definite and quan‐
titative clinical evaluation of the therapeutic results. Whenever it is done, the effectiveness 
of the US treatment is often evaluated only by using clinical tests and pain scores such as 
VAS or NRS, which give a subjective rather than quantitative and objective measure. It is 
therefore necessary, in order to obtain an objective assessment of the US treatment effec‐
tiveness, a multimodal evaluation of patients, including clinical, functional and pain scores, 
and also including a sonographic quantitative investigation of the local phlogosis before and 
after the treatment and of the final edema resolution. In a pilotal study [23] performed at the 
Department of Physical Therapy and Rehabilitation Medicine at Turin University from May 
Clinical diagnosis US parameters selected (intensity (W/cm2); frequency 
(MHz); modalities; duration (minute)
Impingements and tendonitis BBLC 1.5; 3; pulsed (DC 25%); massage; 10
Frozen shoulder 1.5; 1; continuos; massage; 5
Rotator cuff tendinopathy 1.5; 1; pulsed (DC 25%); massage; 10
Suvraspinal tendonitis and bursitis SAD 1.5; 3; pulsed (DC 25%); massage; 10
Impingement syndrome 1.5; 3; pulsed (DC 25%); massage; 10
Tendonitis BBLC 1.5; 1; pulsed (DC 25%); massage; 10
Tendonitis BBLC and rotator cuff 1.5; 3; pulsed (DC 25%); massage; 10
Table 2. ‘Treatment planning’ based on the different anatomical and functional features in shoulders.
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to September 2015, 10 patients with shoulder pain and functional limitation, due to biceps 
brachii long head muscle or rotator cuff tendonitis, bursitis, intra‐articular effusion, without 
indication for surgical treatment were enrolled. After a preliminary physiatric evaluation, 
each patient underwent the US and other successive rehabilitative treatments. The US thera‐
peutic protocol is based on 10 sessions in consecutive days for an overall period of 2 weeks. 
US treatments were then designed and performed by selecting the specific US parameters 
values and the treatment modalities for each patient in consideration of their specific clini‐
cal, functional and sonographic findings. A preliminary sonographic study was performed in 
order to quantify edema, phlogosis or effusion. Relevant images were saved and transferred 
on PC for further elaboration. As far as the other US parameter values are concerned, a care‐
ful evaluation of the estimated depth of the lesion suggested the choice of the frequency of 
1 MHz for deep and of 3 MHz for more superficial treatment sites. Moreover, depending 
on the expected therapeutic increase in temperature at the lesion, the ‘continuous’ modality 
was selected to induce more heat deposition (for a shorter time) while the ‘pulsed’ modal‐
ity, with a Duty Cycle (i.e. the US emitting time related to the total time length of the cycle) 
selected at 25% was preferred for longer time (10 min) treatments. A multimodal assessment 
(clinical, functional and sonographic) of the actual pathology was performed before the US 
treatment, recording shoulder pain, ROM, strength, functional parameters and sonographic 
imaging. Pain was estimated using the Numeric Rating Scale (NRS), Constant Score and 
DASH scale were used for shoulder's function evaluation [25, 26]. The same procedure for 
result assessment was followed at the end of the US treatment. The sonographic examination 
was performed following a standardized procedure for the shoulder imaging named musku‐
loskeletal ultrasonographic exam (MSUS) which satisfactorily detects the main findings of the 
phlogosis process [27]. MSUS exam was performed before the US treatment session and at 
the end of the last US session by a rehabilitation medical specialist, using an Edge Ultrasound 
System (Sonosite, USA) connected to a 7.5 MHz frequency probe. To each alteration, a semi‐
quantitative score from 0 to 3 was given (0: no alterations; 1, 2, 3: low, mid and high inflam‐
matory alterations). Single scores were added to give a total value (total score), indicating 
the global index of phlogosis of the shoulder in each patient [28]. All patients enrolled in 
the study showed a significant reduction of shoulder pain and functional limitations with 
NRS and DASH scores significantly improved. Sonographic imaging supports clinical data, 
showing a considerable reduction of bursa or tendon's area of phlogosis. The previous expe‐
rience obtained in monitoring temperatures in a realistic model (phantom) heated with US 
with different modalities have been useful in defining more precisely which values of the US 
parameters and which treatment modalities would be optimal to induce the expected thermal 
effects for each specific patient.
4. Conclusions
Paying attention to the equipment efficiency, the ‘in vitro’ and ‘in vivo’ investigations of the 
thermal field induced by any specific US probe working at different modalities and to the 
specific characteristics of the joint to be treated, US physiotherapy may dramatically improve 
its quality and possibly show evidences of effectiveness which are nowadays lacking.
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